Coronavirus

DCGI approves Covaxin, Oxford-AstraZeneca vaccines for emergency use

The Drugs Controller General of India (DCGI), on Sunday, has approved Bharat Biotech’s Covaxin and Oxford-AstraZeneca vaccines for emergency usage. These are the first-ever vaccines that will be used in the country to fight COVID-19.

The overall efficacy of the Oxford-AstraZeneca Covid-19 vaccine was 70.42%, while Bharat Biotech’s Covaxin was “safe and provides a robust immune response”, DCGI’s VG Somani said.

He added that they wouldn’t approve vaccine if it is not a hundred per cent safe. He also added that the vaccine does have some side effects like mild fever, pain which are very common.

“We’ll never approve anything if there is slightest of safety concern. The vaccines are 100% safe. Some side effects like mild fever, pain and allergy are common for every vaccine. It (people may get impotent) is absolute rubbish,” VG Somani said.

Related posts

Now you can order food through Instagram

Penbugs

தமிழகத்தில் இன்று 6129 பேர் டிஸ்சார்ஜ்

Penbugs

Still no clarity on our next series: Poonam Yadav

Penbugs

சாத்தான்குளம் வழக்கில் கைதான எஸ்எஸ்ஐ பால்துரை கொரோனாவால் மரணம்

Penbugs

TN lockdown- New restrictions announced

Penbugs

COVID19: Sonu Sood launches toll free number to help migrant workers reach home

Penbugs

தமிழக அரசின் முடிவை ஏற்க மறுத்த ஏஐசிடிஇ

Penbugs

Kimberly, Trump Junior’s girlfriend tested positive for COVID19

Penbugs

IPL 2020: All 13 CSK members tested negative

Penbugs

விநாயகர் சிலைகளை பொது இடங்களில் வைத்து வழிபட அனுமதி இல்லை – தமிழக அரசு

Kesavan Madumathy

Fake: No, Bharat Biotech’s VP is not getting COVAXIN

Penbugs

தமிழகத்தில் இன்று ஒரே நாளில் 4910 பேர் டிஸ்சார்ஜ்

Kesavan Madumathy

Leave a Comment